• Forum
  • Documents
  • FAQ
  • Opportunities
  • Links
Cost Action MP1301
  • Home
  • The project
    • Background
      • Current state of knowledge
      • Reasons for the Action
      • Complementarity with other research programmes
    • Objectives and benefits
      • Potential impact of the Action
      • Target groups/end users
    • Scientific programme
      • WG1 Design and synthesis of raw materials
      • WG2 Manufacturing and characterization of 3D-porous scaffolds
      • WG3 Functionalization of implants for improved functional and therapeutic effects
      • WG4 In vitro evaluation of the performance
    • POSTER
    • Organisation
      • Timetable
      • Economic Dimension
      • Dissemination Plan
      • Management Committee
  • Partners
    • Member list
    • Presentation of partners
      • WG1 Design and synthesis of raw materials
      • WG2 Manufacturing and characterization of 3D-porous scaffolds
      • WG3 Functionalization of implants for improved functional and therapeutic effects
      • WG4 In vitro evaluation of the performance
  • Events
    • Meetings
    • Workshops
    • STSMs
    • Training Schools
    • Medias
  • News
  • Contact
  • Search
  • Menu

WG2 Manufacturing and characterization of 3D-porous scaffolds

You are here: Home / Partners / Presentation of partners / WG2 Manufacturing and characterization of 3D-porous scaffolds

Aachen - RWTH Aachen University Hospital (DE)

Belfast - Queen’s University (UK)

Brno - Masaryk (CZ)

Ferrara- BEL at unife (IT)

Kaunas - KTU (LT)

Krakow - AGH (PL)

Geel - KU Leuven (BE)

Louvain-la-Neuve - Visyos (BE)

Lyon - Mateis - INSA (FR)

Reykjavik - ICI (IS)

Sheffield - GTS (UK)

Stuttgart - IFKB (DE)

Torino - POLITO GLANCE (IT)

Vienna - LITHOZ (AT)

Vienna - VIENNA UNIVERSITY OF TECHNOLOGY (AT)

Zagreb - MPL RBI Croatia (HR)

  • Member list
    • PartnersList
  • Presentation of partners
    • WG1 Design and synthesis of raw materials
    • WG2 Manufacturing and characterization of 3D-porous scaffolds
    • WG3 Functionalization of implants for improved functional and therapeutic effects
    • WG4 In vitro evaluation of the performance

Search

Parnters

Categories

  • Conference
  • STMS
  • Uncategorized

Archive

  • December 2017
  • September 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • December 2016
  • May 2016
  • April 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • July 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • October 2014
© Copyright - COST Action MP1301 - website by LuxApps
  • FAQ
  • Contact
Scroll to top